Press releases

^{Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.}

YearType

2026

2 Jul 2026, 13:00

Hansa Biopharma participating in Wedbush PacGrow Renal Summit

1 Jul 2026, 14:30 | Regulatory

Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

· SERB assumes responsibility for the commercialization of Idefirix in transplantation in the EU, UK, Switzerland, Norway, Liechtenstein, Iceland and MENA region
· The transaction significantly strengthens Hansa’s financial position and enables a robust US launch, subject to US approval of imlifidase

24 Jun 2026, 22:40

Hansa Biopharma announces ConfIdeS Phase 3 Abstract Selected for ‘What’s Hot, What’s New’ Plenary at ATC 2026

15 Jun 2026, 07:00

Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer

12 Jun 2026, 07:00

Hansa Biopharma invite to Capital Markets Day 2026 in New York

10 Jun 2026, 08:00

Hansa Biopharma appoints Fredrik Röök as VP Business Development

2 Jun 2026, 12:35

Hansa Biopharma participating in Jefferies Global Healthcare Conference in New York

1 Jun 2026, 17:00 | Regulatory

Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)